Bulletin
Investor Alert

New York Markets Close in:

Horizon Therapeutics PLC

NAS: HZNP

GO
/marketstate/country/us

Market open

 --Real time quotes

Jan 21, 2022, 9:49 a.m.

/zigman2/quotes/206690250/composite

$

85.56

Change

-1.01 -1.17%

Volume

Volume 149,486

Real time quotes

/zigman2/quotes/206690250/composite

Previous close

$ 86.57

$ 85.56

Change

-1.01 -1.17%

Day low

Day high

$85.26

$86.50

Open

52 week low

52 week high

$70.15

$120.54

Open

Insider Actions for Horizon Therapeutics PLC

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
01/14/2022 Timothy P. Walbert
Chairman, President and CEO; Director
25,000   Disposition at $90.02 per share. 2,250,500
01/14/2022 Timothy P. Walbert
Chairman, President and CEO; Director
25,000   Derivative/Non-derivative trans. at $22.14 per share. 553,500
01/06/2022 Andy Pasternak
EVP and Chief Business Officer
349   Disposition at $100.23 per share. 34,980
01/06/2022 Andy Pasternak
EVP and Chief Business Officer
6,438   Disposition at $99.85 per share. 642,834
01/06/2022 Andy Pasternak
EVP and Chief Business Officer
700   Disposition at $98.33 per share. 68,831
01/06/2022 Andy Pasternak
EVP and Chief Business Officer
500   Disposition at $97.3 per share. 48,650
01/05/2022 Timothy P. Walbert
Chairman, President and CEO; Director
3,636   Derivative/Non-derivative trans. at $101.84 per share. 370,290
01/05/2022 Timothy P. Walbert
Chairman, President and CEO; Director
174,906   Derivative/Non-derivative trans. at $101.84 per share. 17,812,427
01/05/2022 Jeffrey W. Sherman
EVP and Chief Medical Officer
37,675   Derivative/Non-derivative trans. at $0 per share. 0
01/05/2022 Paul W. Hoelscher
EVP, CFO
50,666   Derivative/Non-derivative trans. at $101.84 per share. 5,159,825
01/05/2022 Barry J. Moze
EVP, Chief Admin. Officer
49,841   Derivative/Non-derivative trans. at $101.84 per share. 5,075,807
01/05/2022 Michael A. DesJardin
EVP, Technical Operations
41,276   Derivative/Non-derivative trans. at $101.84 per share. 4,203,547
01/05/2022 Miles W. McHugh
Sr VP & Princ. Acctg Officer
8,175   Derivative/Non-derivative trans. at $101.84 per share. 832,542
01/05/2022 Andy Pasternak
EVP and Chief Business Officer
21,710   Derivative/Non-derivative trans. at $101.84 per share. 2,210,946
01/05/2022 Elizabeth H.Z. Thompson
EVP, Research & Development
7,030   Derivative/Non-derivative trans. at $101.84 per share. 715,935
01/05/2022 Timothy P. Walbert
Chairman, President and CEO; Director
8,043   Derivative/Non-derivative trans. at $0 per share. 0
01/05/2022 Timothy P. Walbert
Chairman, President and CEO; Director
241,750   Derivative/Non-derivative trans. at $0 per share. 0
01/05/2022 Jeffrey W. Sherman
EVP and Chief Medical Officer
52,570   Derivative/Non-derivative trans. at $0 per share. 0
01/05/2022 Paul W. Hoelscher
EVP, CFO
66,822   Derivative/Non-derivative trans. at $0 per share. 0
01/05/2022 Barry J. Moze
EVP, Chief Admin. Officer
64,959   Derivative/Non-derivative trans. at $0 per share. 0
01/05/2022 Michael A. DesJardin
EVP, Technical Operations
53,734   Derivative/Non-derivative trans. at $0 per share. 0
01/05/2022 Miles W. McHugh
Sr VP & Princ. Acctg Officer
18,289   Derivative/Non-derivative trans. at $0 per share. 0
01/05/2022 Andy Pasternak
EVP and Chief Business Officer
48,839   Derivative/Non-derivative trans. at $0 per share. 0
01/05/2022 Elizabeth H.Z. Thompson
EVP, Research & Development
13,999   Derivative/Non-derivative trans. at $0 per share. 0
01/05/2022 Timothy P. Walbert
Chairman, President and CEO; Director
152,896   Award at $0 per share. 0
01/05/2022 Jeffrey W. Sherman
EVP and Chief Medical Officer
32,301   Award at $0 per share. 0
01/05/2022 Paul W. Hoelscher
EVP, CFO
47,375   Award at $0 per share. 0
01/05/2022 Barry J. Moze
EVP, Chief Admin. Officer
47,375   Award at $0 per share. 0
01/05/2022 Michael A. DesJardin
EVP, Technical Operations
32,301   Award at $0 per share. 0
12/31/2021 Timothy P. Walbert
Chairman, President and CEO; Director
7,522   Disposition at $108.55 per share. 816,513
12/31/2021 Timothy P. Walbert
Chairman, President and CEO; Director
67,478   Disposition at $108.02 per share. 7,288,973
12/31/2021 Timothy P. Walbert
Chairman, President and CEO; Director
25,000   Derivative/Non-derivative trans. at $22.14 per share. 553,500
12/28/2021 Paul W. Hoelscher
EVP, CFO
8,575   Disposition at $110 per share. 943,250
12/28/2021 Paul W. Hoelscher
EVP, CFO
8,575   Derivative/Non-derivative trans. at $15.96 per share. 136,857
12/13/2021 Jeffrey W. Sherman
EVP and Chief Medical Officer
50   Gift at $0 per share. 0
12/07/2021 Andy Pasternak
EVP and Chief Business Officer
1,525   Disposition at $100 per share. 152,500
12/03/2021 Paul W. Hoelscher
EVP, CFO
1,049   Gift at $0 per share. 0
12/01/2021 Miles W. McHugh
Sr VP & Princ. Acctg Officer
79,484   Disposition at $106.62 per share. 8,474,584
12/01/2021 Miles W. McHugh
Sr VP & Princ. Acctg Officer
79,484   Derivative/Non-derivative trans. at $22.14 per share. 1,759,775
11/30/2021 Timothy P. Walbert
Chairman, President and CEO; Director
13,487   Disposition at $103.54 per share. 1,396,443
11/30/2021 Timothy P. Walbert
Chairman, President and CEO; Director
15,875   Disposition at $102.62 per share. 1,629,092
11/30/2021 Timothy P. Walbert
Chairman, President and CEO; Director
20,638   Disposition at $101.48 per share. 2,094,344

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
26 Purchases
43 Sales
1,252,485
891,028
Last 6 months
42 Purchases
67 Sales
1,708,570
1,415,328
Last 12 months
77 Purchases
133 Sales
2,033,556
2,131,355

Officers and Executives

Mr. Timothy P. Walbert
Chairman, President & Chief Executive Officer
Mr. Paul W. Hoelscher
Chief Financial Officer & Executive Vice President
Dr. Karin Rosen
Chief Scientific Officer
Dr. Elizabeth H.Z. Thompson
Executive Vice President-Research & Development
Dr. Jeffrey W. Sherman
Chief Medical Officer & Executive Vice President
Dr. Jeffrey D. Kent
Executive VP-Medical Affairs & Outcomes Research
Mr. Barry J. Moze
Chief Administrative Officer & Executive VP
Mr. Andy Pasternak
Chief Strategy Officer & Executive Vice President
Mr. Daniel A. Camardo
President-US & Executive Vice President
Mr. Ray Gordon
Managing Director
Mr. Aaron Cox
Executive Vice President-Finance
Ms. Amy Grahn
Senior VP-Global Clinical Development & Operations
Mr. Vikram Karnani
President-International & Executive Vice President
Mr. Michael A. DesJardin
Executive VP-Technical Operations & Quality
Mr. Michael G. Grey
Director
Mr. Miles W. McHugh
Chief Accounting Officer & Senior Vice President
Ms. Tina Ventura
Senior Vice President-Investor Relations
Ms. Irina P. Konstantinovsky
Chief Human Resources Officer & Executive VP
Ms. Jennifer T. Lee
Secretary
Mr. Brian K. Beeler
Executive Vice President & General Counsel
Ms. Marilyn Vetter
Vice President-Government & Public Affairs
Dr. Susan Mahony
Independent Director
Dr. Jeff Himawan
Independent Director
Mr. William Francis Daniel
Independent Director
Ms. Pascale Witz
Independent Director
Dr. James Samuel Shannon
Independent Director
Mr. H. Thomas Watkins
Independent Director
Mr. Gino Santini
Independent Director
Trending Tickers
  • /zigman2/quotes/208747069/composite GEVO+7.77%
  • /zigman2/quotes/228313454/composite CNTX+0.36%
  • /zigman2/quotes/214140886/composite CHPT+5.01%
  • /zigman2/quotes/208173073/composite SFIX+4.61%
  • /zigman2/quotes/222642382/composite OLMA+5.43%
X
Powered by StockTwits
Link to MarketWatch's Slice.